dienogest: Clinical Trials

58 trials of dienogest, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

36 completed, 12 unknown, 3 recruiting, 2 terminated. 14 Phase 3, 12 Phase 4, 8 Phase 2, 7 Phase 1, 6 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 314Completed 9, Unknown 3, Recruiting 1, Suspended 1
Phase 412Unknown 7, Completed 3, Recruiting 1, Terminated 1
Phase 28Completed 4, Suspended 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 17Completed 6, Not yet recruiting 1
Not applicable6Completed 4, Unknown 2
Early Phase 11Completed 1

Follow dienogest: new trials by email Literature Review of dienogest trials Research Report on dienogest

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis
Indole-3-carbinol, Dienogest - Endometriosis
Phase 3RecruitingAlcea2902025-09-112025-09-18
Ultra-Safe Hormonal Strategy: Transdermal Estradiol Added to Progestins for Endometriosis
Drospirenone 4 mg orally, Dienogest 2 mg orally - Endometriosis
Active not recruitingFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1382025-08-112025-10-02
Ttt of Adenomyosis
Dienogest 2 mg orally, UAE - Adenomyosis
Phase 1Not yet recruitingAl-Azhar University1002025-01-012024-12-06
Comparison Between the Effects of Implantable Gestrinone and Oral Dienogest in the Treatment of Endometriosis
Implantable gestrinone, Oral Dienogest - Endometriosis
Phase 4RecruitingBio Meds Pharmaceutica Ltda702024-07-302026-10-20
Role of Medical Treatment in Endometriosis Patients Undergoing ICSI
Combined contraceptive pills (Yasmin) - Endometriosis
Not applicableUnknownCairo University1292024-07-012024-08-29
"Quick-starting" of a Quadriphasic Contraceptive Pills, 1 - 3 mg Estradiol Valerate/ 2 - 3 mg Dienogest VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition
Quadriphasic Estradiol valerate 1 - 3 mg/ Dienogest 2 - 3 mg (26/2), Ethinylestradiol (EE) 20 mcg/Gestodene 75 mcg (21/7) - Ultrasound Finding: Ovulation Inhibition, Ovarian Activities, Cervical Mucus
Not applicableCompletedChulalongkorn University402024-05-092026-08-25
Salivary microRNA in Endometriosis: Correlation With Response to Progestin Therapy
Dienogest 2 MG - Endometriosis
RecruitingUniversity of Udine902024-04-222025-04-02
Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative Surgery
Dienogest, Depo Medroxyprogesterone acetate, Leuprolide (as Leuprolide Acetate) - Endometriosis Ovary
Phase 3CompletedUniversitas Diponegoro802023-09-042024-12-11
Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma
Dienogest 2 MG, N-acetyl cysteine - Uterine Leiomyoma
Phase 2 / Phase 3CompletedAin Shams University402023-09-012024-12-16
Adenomyosis and ART
Enantone, Dienogest 2 MG (milligram), long GnRH agonist or flexible GnRH antagonist protocol. - Adenomyosis
Phase 4UnknownAzienda Ospedaliero-Universitaria di Modena5002023-03-272023-07-10
Effect of Management of the Endometrioma on Ovarian Reserve
Dienogest, Laparoscopic cystectomy, Control with ultrasound without other type of intervention - Endometrioma
WithdrawnUniversity of Valencia2023-03-142026-07-08
Comparisons of the Therapeutic Effects of Dienogest and Danazol on Endometriosis
Dienogest, Danazol - Endometriosis
Phase 3UnknownFar Eastern Memorial Hospital1202023-02-252023-03-29
The Use of Drospirenone/Estetrol, Nomegestrol Acetate/Estradiol and Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation
Drospirenone / Estetrol, Nomegestrol Acetate / Estradiol, Ethinylestradiol / Dienogest - Endometrial Polyp, Endometrial Diseases
Phase 4CompletedUniversity of Palermo1502023-01-012024-04-08
The Use of Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation
Ethinylestradiol/Dienogest 0.03mg/2mg - Endometrial Polyp, Endometrial Diseases
Phase 4CompletedUniversity of Palermo802023-01-012024-04-22
A Study to Learn More About How Safe Dienogest is and How Well it Works Under Real World Conditions in Indian Women With Endometriosis
Dienogest (BAY86-5258, Visanne) - Endometriosis Associated Pelvic Pain
CompletedBayer1602022-05-132025-01-22
Bioavailability of Estradiol Valerate and Dienogest 2 mg/2 mg With Regards to Reference Product
Estradiol Valerate and Dienogest 2 mg/ 2 mg Test Drug tablet, Estradiol Valerate and Dienogest 2 mg/ 2 mg Reference Product tablet - Bioequivalence
Phase 1CompletedLaboratorios Andromaco S.A.102022-03-122022-04-18
The Effect of Dionegest Use on the Frequency of Fibromyalgia in Endometriosis
Dienogest - Fibromyalgia, Endometriosis Ovary
CompletedGaziosmanpasa Research and Education Hospital612021-06-302023-02-23
The Effect of Dienogest vs. Norethindrone Acetate Treatment in Endometriosis
Dienogest Pill, Norethindrone Acetate - Endometriosis
Not applicableCompletedUludag University702021-04-012023-07-21
Goserline Acetate VS Dienogest in Endometriosi
Zoladex, Visanne - Endometriosis
Phase 4UnknownMansoura University402020-12-252021-10-20
A Study to Learn More About Using Dienogest to Treat Endometriosis in Chinese Participants
Dienogest (Visanne,BAY86_5258) - Endometriosis
CompletedBayer9682020-10-282023-12-12

Showing 20 of 58. Sign in to see all of them.

Conditions studied

Endometriosis (28)  ·  Adenomyosis (5)  ·  Infertility (2)  ·  Metrorrhagia (2)  ·  Myofibroma (2)  ·  Uterine Diseases (2)  ·  Anorexia Nervosa (1)  ·  Feeding and Eating Disorders (1)  ·  Fibromyalgia (1)  ·  Insulin Resistance (1)  ·  Leiomyoma (1)  ·  Medication Adherence (1)  ·  Menorrhagia (1)  ·  Pelvic Pain (1)  ·  Premenstrual Syndrome (1)

Sponsors

Bayer (17)  ·  Laboratorios Andromaco S.A. (3)  ·  Ain Shams University (2)  ·  American University of Beirut Medical Center (2)  ·  Cairo University (2)  ·  University of Palermo (2)  ·  Al-Azhar University (1)  ·  Alcea (1)  ·  Assiut University (1)  ·  Azienda Ospedaliero-Universitaria di Modena (1)  ·  Bagcilar Training and Research Hospital (1)  ·  Bio Meds Pharmaceutica Ltda (1)  ·  Chulalongkorn University (1)  ·  Estetra (1)  ·  Far Eastern Memorial Hospital (1)

Countries

Egypt (8)  ·  Germany (7)  ·  Italy (7)  ·  Finland (4)  ·  United States (4)  ·  Canada (3)  ·  Chile (3)  ·  Indonesia (3)  ·  Lebanon (3)  ·  South Korea (3)  ·  Spain (3)  ·  Taiwan (3)  ·  Turkey (Türkiye) (3)  ·  China (2)  ·  Czechia (2)

Top investigators

Ahmed Taha, Professor (1)  ·  Alaa Mosbah (1)  ·  Amr Mahmoud, lecturer (1)  ·  Annina Haverinen, MD, PhD student (1)  ·  Antoine Abu Musa, MD (1)  ·  Chi-Hau Chen, MD, PhD (1)  ·  Dan Apter, M.D. (1)  ·  Dina Chamsi, MD (1)  ·  Engin Oral, Prof.Dr. M.D (1)  ·  Enrico Colli, MD (1)  ·  Fabio Barra, MD, PhD (1)  ·  Giuseppe Vizzielli, prof (1)  ·  Gurkan Uncu, Prof. (1)

Results publications

PMID 21774563, PMID 22240178, PMID 18653184, PMID 21422847, PMID 21784734, PMID 22128200, PMID 22927764, PMID 23439617, PMID 23638631, PMID 24713413, PMID 28911925, PMID 29631553, PMID 29845696, PMID 30461337, PMID 31096979, PMID 32303765, PMID 32767677, PMID 33590656, PMID 33784989, PMID 34370858, PMID 34826668, PMID 34961515, PMID 35112299, PMID 35123042, PMID 35909329, PMID 36084710, PMID 36416543, PMID 36576860, PMID 37523477, PMID 39329272, PMID 40233572, PMID 41065045

NIH funding

2008 (2), 2009 (2), 2005 (1), 2017 (1)